Abstract Body

Background

Monkeypox virus (MPXV) is a zoonotic virus endemic to Africa that has recently spread globally, becoming the first human orthopoxvirus (OPXV) since smallpox eradication. The MPXV global outbreak strain (Clade IIb, lineage B) derives from Clade IIb lineage A strains that circulate and remain endemic to Africa with limited human-to-human transmission. Clinically, lineage A-infected individuals exhibit more severe disease including substantial viral dissemination (>100 lesions per individual) relative to lineage B patients (<10 localised anogenital lesions). Lineages A and B differ by 51 nucleotides, most of which are compatible with host APOBEC3-mediated mutation. The consequences of these mutations to the biology of the virus remain unclear. 

Methods

Here we used comparative virology to determine the phenotypic properties of MPXV lineage B relative to the closest ancestral lineage A and related OPXV. 

Results

We found that both global and endemic MPXV replicated to the same extent in multiple cell types, but the global lineage B virus produced lower extracellular virus titres and showed defects in long-range spread. Both viruses had extensive capacity to suppress human innate antiviral responses, with a major role for the viral cGAMP nuclease (poxin). Consistent with this, RNAseq in infected fibroblasts and macrophages showed no significant induction of interferon (IFN) or antiviral-related KEGG pathways with either MPXV strain. Both viruses however induced strong inflammatory cytokine responses that have also been observed in patients and, interestingly, were absent with other OPXV. Importantly, comparative transcriptomics revealed defects in innate immune control by global MPXV, including IFNβ induction, increased innate immune signalling gene expression and enhanced MAP kinase activation. Furthermore, global MPXV had reduced capacity to suppress interleukin-1β-mediated immune responses. Consistent with the above, the global strain had reduced virulence in a mouse model of MPXV infection relative to the ancestral endemic strain. 

Conclusions

Our findings reveal phenotypic differences between these two clade IIb viruses and demonstrate attenuation of globally circulating MPXV concomitant with human transmission. Our data may help explain clinical observations that lineage B is associated with milder disease. Finally, our work reveals that the APOBEC3-like mutational footprint is not only a signature of MPXV transmission amongst humans but also drives phenotypic changes.

Table or Figure